Legislation and Legislative Advocacy
The American Hospital Association (AHA) shares resources on health care legislation being considered by the U.S. House and Senate and legislative advocacy opportunities for hospitals and health systems.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups…
The AHA today urged leaders of the Senate Committee on Appropriations to allow funding for the adoption of a unique patient identifier as part of fiscal year 2020 Labor, Health and Human Services, and Education, and Related Agencies appropriations bill.
The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption available to commercial health insurers for anticompetitive conduct.
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the use of prior authorization under Medicare Advantage plans.
The House of Representatives today passed and sent to the President a Medicaid-related bill (H.R. 3253) that includes a provision extending the Certified Community Behavioral Health Clinic demonstration program through Sept. 13.
Medicaid disproportionate share hospital payments to eligible hospitals covered 51% of their uncompensated care costs in 2014, the most recently available audited data.
The AHA, AAMC and FAH agree with the Committee’s goal of reducing the price of drugs, and applaud many of the steps outlined in the description of the Chairman’s Mark of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. However, have serious concerns regarding the provisions that…
The House of Representatives today passed 284-149 a two-year budget agreement (H.R. 3877) that increases discretionary funding limits and suspends the debt limit for two years, through July 31, 2021.
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the Prescription Drug Pricing Reduction Act of 2019.
The House of Representatives last night voted 419-6 to pass legislation (H.R. 748) that would repeal the 40% excise tax on high-value employer-sponsored health plans set to begin in 2022.